» Articles » PMID: 39202451

Novel Loss-of-Function Variants in Infertile Males Upgrade the Gene-Disease Clinical Validity Classification for and Male Infertility to Strong

Overview
Journal Genes (Basel)
Publisher MDPI
Date 2024 Aug 29
PMID 39202451
Authors
Affiliations
Soon will be listed here.
Abstract

Male infertility affects approximately 7% of the male population, and about 15% of these cases are predicted to have a genetic etiology. One gene implicated in autosomal dominant male infertility, , encodes a protein critical for the synapsis of homologous chromosomes during meiosis I, resulting in impaired spermatogenesis. However, the clinical validity of the gene-disease pair was previously categorized as on the border of limited and moderate due to few reported cases. This study investigates the genetic cause of infertility for three unrelated Chinese patients with oligoasthenozoospermia. Whole exome sequencing (WES) and subsequent Sanger sequencing revealed novel heterozygous loss-of-function (LOF) variants in (c.89dup, c.946_947del, and c.4378_4379del). These cases, combined with the previously reported cases, provide strong genetic evidence supporting an autosomal dominant inheritance pattern. The experimental evidence also demonstrates a critical role for in spermatogenesis. Collectively, this updated assessment of the genetic and experimental evidence upgrades the gene-disease association strength of and autosomal dominant male infertility from on the border of limited and moderate to strong. The reclassification improves variant interpretation and qualifies it for the inclusion on diagnostic male infertility gene panels and prioritization in whole exome or genome studies for related phenotypes. These findings therefore improve the clinical interpretation of LOF variants.

Citing Articles

Construction of regulatory T cells specific genes predictive models of prostate cancer patients based on machine learning: a computational analysis and in vitro experiments.

Zhou Z, Liang C Discov Oncol. 2025; 16(1):178.

PMID: 39948230 PMC: 11825432. DOI: 10.1007/s12672-025-01862-3.

References
1.
Schilit S, Menon S, Friedrich C, Kammin T, Wilch E, Hanscom C . SYCP2 Translocation-Mediated Dysregulation and Frameshift Variants Cause Human Male Infertility. Am J Hum Genet. 2019; 106(1):41-57. PMC: 7042487. DOI: 10.1016/j.ajhg.2019.11.013. View

2.
McKenna A, Hanna M, Banks E, Sivachenko A, Cibulskis K, Kernytsky A . The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res. 2010; 20(9):1297-303. PMC: 2928508. DOI: 10.1101/gr.107524.110. View

3.
Schilit S . Recent advances and future opportunities to diagnose male infertility. Curr Sex Health Rep. 2019; 11(4):331-341. PMC: 6919557. DOI: 10.1007/s11930-019-00225-8. View

4.
Schalk J, Offenberg H, Peters E, Groot N, Hoovers J, Heyting C . Isolation and characterization of the human SCP2 cDNA and chromosomal localization of the gene. Mamm Genome. 1999; 10(6):642-4. DOI: 10.1007/s003359901062. View

5.
. The Genotype-Tissue Expression (GTEx) project. Nat Genet. 2013; 45(6):580-5. PMC: 4010069. DOI: 10.1038/ng.2653. View